Table 5 Serum cytokines concentration before and after NK cell therapy
| Â | Baseline (day 0) (pg/ml) | Post administration (day 42) (pg/ml) | p value |
|---|---|---|---|
IL-1β | 4.007 ± 7.155 | 6.438 ± 13.22 | 0.25 |
IL-1RA | 893.3 ± 2154 | 983.0 ± 2550 | 1 |
IL-2 | 37.16 ± 22.54 | 37.45 ± 29.48 | 0.8203 |
IL-4 | 2.456 ± 0.6683 | 2.600 ± 0.7691 | 0.4961 |
IL-5 | 4.029 ± 2.191 | 4.171 ± 3.156 | 1 |
IL-6 | 38.62 ± 47.26 | 45.43 ± 58.69 | 0.3594 |
IL-7 | 3.827 ± 3.984 | 4.724 ± 6.224 | 0.8203 |
IL-8 | 26.94 ± 9.571 | 30.73 ± 16.71 | 0.4258 |
IL-9 | 31.33 ± 28.77 | 32.87 ± 37.69 | 0.4258 |
IL-10 | 26.28 ± 30.72 | 27.71 ± 39.37 | 0.3008 |
IL-12p70 | 37.28 ± 50.31 | 47.22 ± 83.46 | 0.9102 |
IL-13 | 14.87 ± 21.99 | 19.05 ± 36.70 | 0.8203 |
IL-15 | 44.33 ± 20.73 | 43.67 ± 28.17 | 0.8203 |
IL-17 | 199.2 ± 89.43 | 185.1 ± 109.2 | 0.4961 |
IFN-γ | 92.13 ± 119.4 | 105.4 ± 141.8 | 0.3594 |
TNF-α | 32.04 ± 45.28 | 38.69 ± 59.64 | 0.0977 |
bFGF | 51.92 ± 31.51 | 53.38 ± 45.84 | 0.7344 |
PDGF-BB | 172.2 ± 108.3 | 191.0 ± 219.0 | 0.9102 |
G-CSF | 55.23 ± 26.89 | 58.08 ± 40.79 | 0.9102 |
GM-CSF | 90.58 ± 75.85 | 94.29 ± 97.23 | 0.7344 |
IP-10 | 287.1 ± 40.88 | 389.2 ± 204.4 | 0.3008 |
MCP-1 | 133.6 ± 33.18 | 122.1 ± 52.29 | 0.2031 |
MIP-1α | 4.972 ± 3.239 | 4.214 ± 2.073 | 0.1641 |
MIP-1β | 275.0 ± 86.68 | 300.6 ± 154.0 | 1 |
Eotaxin | 116.4 ± 193.8 | 123.2 ± 233.4 | 0.7344 |
RANTES | 2157 ± 396.8 | 2445 ± 580.7 | 0.2031 |
VEGF | 92.02 ± 30.85 | 113.2 ± 79.16 | 0.9102 |